Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 6
1967 13
1968 15
1969 14
1970 8
1971 16
1972 10
1973 25
1974 22
1975 18
1976 23
1977 21
1978 32
1979 23
1980 10
1981 21
1982 20
1983 25
1984 33
1985 24
1986 36
1987 21
1988 23
1989 37
1990 45
1991 29
1992 46
1993 38
1994 56
1995 46
1996 40
1997 68
1998 49
1999 65
2000 46
2001 60
2002 54
2003 61
2004 69
2005 60
2006 58
2007 49
2008 55
2009 48
2010 41
2011 36
2012 52
2013 38
2014 22
2015 27
2016 27
2017 20
2018 20
2019 21
2020 21
2021 13
2022 9
2023 3
2024 13
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,803 results

Results by year

Filters applied: . Clear all
Page 1
Haloperidol for the Treatment of Delirium in ICU Patients.
Andersen-Ranberg NC, Poulsen LM, Perner A, Wetterslev J, Estrup S, Hästbacka J, Morgan M, Citerio G, Caballero J, Lange T, Kjær MN, Ebdrup BH, Engstrøm J, Olsen MH, Oxenbøll Collet M, Mortensen CB, Weber SO, Andreasen AS, Bestle MH, Uslu B, Scharling Pedersen H, Gramstrup Nielsen L, Toft Boesen HC, Jensen JV, Nebrich L, La Cour K, Laigaard J, Haurum C, Olesen MW, Overgaard-Steensen C, Westergaard B, Brand B, Kingo Vesterlund G, Thornberg Kyhnauv P, Mikkelsen VS, Hyttel-Sørensen S, de Haas I, Aagaard SR, Nielsen LO, Eriksen AS, Rasmussen BS, Brix H, Hildebrandt T, Schønemann-Lund M, Fjeldsøe-Nielsen H, Kuivalainen AM, Mathiesen O; AID-ICU Trial Group. Andersen-Ranberg NC, et al. N Engl J Med. 2022 Dec 29;387(26):2425-2435. doi: 10.1056/NEJMoa2211868. Epub 2022 Oct 26. N Engl J Med. 2022. PMID: 36286254 Clinical Trial.
Haloperidol or placebo was administered in the ICU for as long as delirium continued and as needed for recurrences. ...RESULTS: A total of 1000 patients underwent randomization; 510 were assigned to the haloperidol group and 490 to the placebo group. Among these pat …
Haloperidol or placebo was administered in the ICU for as long as delirium continued and as needed for recurrences. ...RESULTS: A tot …
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G, Annable L, Campbell W. Chouinard G, et al. J Clin Psychopharmacol. 1989 Aug;9(4):247-53. J Clin Psychopharmacol. 1989. PMID: 2570086 Clinical Trial.
We carried out an 8-month double-blind clinical trial comparing haloperidol decanoate with fluphenazine decanoate in the maintenance treatment of 72 schizophrenic outpatients. ...Both drugs had a similar profile for drug-induced parkinsonism, but there was a trend for diff …
We carried out an 8-month double-blind clinical trial comparing haloperidol decanoate with fluphenazine decanoate in the maintenance …
A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
Vasavan Nair NP, Suranyi-Cadotte B, Schwartz G, Thavundayil JX, Achim A, Lizondo E, Nayak R. Vasavan Nair NP, et al. J Clin Psychopharmacol. 1986 Feb;6(1 Suppl):30S-37S. doi: 10.1097/00004714-198602001-00006. J Clin Psychopharmacol. 1986. PMID: 3514689 Clinical Trial.
Thirty patients with chronic schizophrenia received oral haloperidol and haloperidol decanoate in a two-phase open study. In the first phase, patients were stabilized on haloperidol tablets for 2 weeks, then maintained on a constant daily dose for 2 more week …
Thirty patients with chronic schizophrenia received oral haloperidol and haloperidol decanoate in a two-phase open study. In t …
Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
Chou JC, Douyon R, Czobor P, Volavka J, Cooper TB. Chou JC, et al. Psychiatry Res. 1998 Oct 19;81(1):51-5. doi: 10.1016/s0165-1781(98)00085-7. Psychiatry Res. 1998. PMID: 9829650 Free article. Clinical Trial.
In this study, 23 acutely exacerbated schizophrenic and schizoaffective patients were washed out for at least 6 days and were then treated with haloperidol to achieve fixed low to moderate plasma levels under double-blind conditions. Clinical response, plasma prolactin, an …
In this study, 23 acutely exacerbated schizophrenic and schizoaffective patients were washed out for at least 6 days and were then treated w …
Comparative trial of the antiemetic effects of THC and haloperidol.
Neidhart JA, Gagen MM, Wilson HE, Young DC. Neidhart JA, et al. J Clin Pharmacol. 1981 Aug-Sep;21(S1):38S-42S. doi: 10.1002/j.1552-4604.1981.tb02571.x. J Clin Pharmacol. 1981. PMID: 6271838 Clinical Trial.
A prospective, randomized and double-blinded trial of the comparative effects of delta-9-tetrahydrocannabinol (THC) and haloperidol (H) was begun in February 1980. Patients were randomized to initially receive either THC or haloperidol with cross-over to the other a …
A prospective, randomized and double-blinded trial of the comparative effects of delta-9-tetrahydrocannabinol (THC) and haloperidol ( …
Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia.
Kane JM, Cohen M, Zhao J, Alphs L, Panagides J. Kane JM, et al. J Clin Psychopharmacol. 2010 Apr;30(2):106-15. doi: 10.1097/JCP.0b013e3181d35d6b. J Clin Psychopharmacol. 2010. PMID: 20520283 Clinical Trial.
Treatment-related adverse events (AEs) occurred in 44% and 52%, 57%, and 41% of the asenapine at 5 and 10 mg BID, haloperidol, and placebo groups, respectively. Extrapyramidal symptoms reported as AEs occurred in 15% and 18%, 34%, and 10% of the asenapine at 5 and 10 mg BI …
Treatment-related adverse events (AEs) occurred in 44% and 52%, 57%, and 41% of the asenapine at 5 and 10 mg BID, haloperidol, and pl …
Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA. Santos JL, et al. Biol Psychiatry. 1989 Aug;26(4):381-8. doi: 10.1016/0006-3223(89)90054-1. Biol Psychiatry. 1989. PMID: 2669981 Clinical Trial.
Levels of haloperidol were determined by radioimmunoassay (RIA) in 30 schizophrenic patients (diagnosed according to the criteria of DSM-III), who were treated with fixed doses of this neuroleptic for a period of 21 days. An inverted U-shaped relationship was found between …
Levels of haloperidol were determined by radioimmunoassay (RIA) in 30 schizophrenic patients (diagnosed according to the criteria of …
Sulpiride versus haloperidol, a clinical trial in schizophrenia. A preliminary report.
Munk-Andersen E, Behnke K, Heltberg J, Nielsen H, Gerlach J. Munk-Andersen E, et al. Acta Psychiatr Scand Suppl. 1984;311:31-41. doi: 10.1111/j.1600-0447.1984.tb06857.x. Acta Psychiatr Scand Suppl. 1984. PMID: 6367362 Clinical Trial.
Each patient was treated with sulpiride/haloperidol in random order for 12 weeks with a drug-free period before each treatment phase. ...However, in a few, very "chronic", disturbed, and long-term treated patients, haloperidol appeared more beneficial than sulpiride …
Each patient was treated with sulpiride/haloperidol in random order for 12 weeks with a drug-free period before each treatment phase. …
Haloperidol blood levels and clinical effects.
Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JC, Crowner M, et al. Volavka J, et al. Arch Gen Psychiatry. 1992 May;49(5):354-61. doi: 10.1001/archpsyc.1992.01820050018002. Arch Gen Psychiatry. 1992. PMID: 1586270 Clinical Trial.
This study explored the relationships between plasma levels and the clinical effects of haloperidol in 176 acutely exacerbated schizophrenic or schizoaffective patients. After a single-blind placebo period of 1 week (period 1), they entered the double-blind period 2 random …
This study explored the relationships between plasma levels and the clinical effects of haloperidol in 176 acutely exacerbated schizo …
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
Hamilton SH, Revicki DA, Edgell ET, Genduso LA, Tollefson G. Hamilton SH, et al. Pharmacoeconomics. 1999 May;15(5):469-80. doi: 10.2165/00019053-199915050-00005. Pharmacoeconomics. 1999. PMID: 10537964 Clinical Trial.
MAIN OUTCOME MEASURES AND RESULTS: After acute treatment, BPRS-based clinical improvements were seen in 38 and 27% of olanzapine and haloperidol patients, respectively (p = 0.002). Clinically important improvements on the Quality of Life Scale were achieved during acute tr …
MAIN OUTCOME MEASURES AND RESULTS: After acute treatment, BPRS-based clinical improvements were seen in 38 and 27% of olanzapine and halo …
1,803 results